Age associations with tacrolimus and mycophenolic acid pharmacokinetics in stable Black and White kidney transplant recipients: Implications for health inequities

Age associations with tacrolimus and mycophenolic acid pharmacokinetics in stable Black and White kidney transplant recipients: Implications for health inequities

Abstract Tacrolimus (TAC) and mycophenolic acid (MPA) provide maintenance immunosuppression and is dosed empirically in elderly kidney transplant recipients (KTRs) resulting in health inequities. Limited immunosuppressive pharmacokinetics are available comparing adult ages. This secondary analysis c...

Full description

Bibliographic Details
Main Authors:	Kathleen M. Tornatore, Kristopher Attwood, Rocco C. Venuto, Brian Murray
Format:	Article
Language:	English
Published:	Wiley 2023-05-01
Series:	Clinical and Translational Science
Online Access:	https://doi.org/10.1111/cts.13495

Similar Items

Beyond Single Nucleotide Polymorphisms: CYP3A5∗3∗6∗7 Composite and ABCB1 Haplotype Associations to Tacrolimus Pharmacokinetics in Black and White Renal Transplant Recipients
by: Daniel A. Brazeau, et al.
Published: (2020-08-01)

Comparison of P‐glycoprotein function in peripheral blood mononuclear cells ex vivo in stable Black and White male and female kidney transplant recipients
by: Kathleen M. Tornatore, et al.
Published: (2023-02-01)

Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients
by: Holly Mansell, et al.
Published: (2022-07-01)

Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants
by: Seung Seok Han, et al.
Published: (2012-09-01)

Pharmacokinetics of Mycophenolate Mofetil and Development of Limited Sampling Strategy in Early Kidney Transplant Recipients
by: Jun Zhang, et al.
Published: (2018-08-01)

Conversion to prolonged release tacrolimus formulation in stable kidney transplant recipients
by: SHENG-WEN WU, et al.
Published: (2013-08-01)

Estimation of Mycophenolic Acid Exposure in Heart Transplant Recipients by Population Pharmacokinetic and Limited Sampling Strategies
by: Xipei Wang, et al.
Published: (2021-11-01)

Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen-Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil.
by: Opas Traitanon, et al.
Published: (2019-01-01)

Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipients
by: Amy Lu, et al.
Published: (2010-09-01)

Effect of conversion from azathioprine to mycophenolate mofetil on renal function in stable kidney transplant recipients
by: Mehmet Usta, et al.
Published: (2019-10-01)

Impact of Fasting Status and Circadian Variation on the Pharmacokinetics of Mycophenolate Mofetil and the Glucuronide Metabolite in Renal Transplant Recipients
by: Ole Martin Drevland, MSc, et al.
Published: (2023-03-01)

Increased Exposure of Tacrolimus by Co-administered Mycophenolate Mofetil: Population Pharmacokinetic Analysis in Healthy Volunteers
by: Jae Hyun Kim, et al.
Published: (2018-01-01)

Impacts of High Intra- and Inter-Individual Variability in Tacrolimus Pharmacokinetics and Fast Tacrolimus Metabolism on Outcomes of Solid Organ Transplant Recipients
by: Charat Thongprayoon, et al.
Published: (2020-07-01)

Meltdose Tacrolimus Population Pharmacokinetics and Limited Sampling Strategy Evaluation in Elderly Kidney Transplant Recipients
by: Jasper Kamp, et al.
Published: (2023-12-01)

Conversion to Combined Therapy with Sirolimus and Mycophenolate Mofetil Improved Renal Function in Stable Renal Transplant Recipients
by: Meng-Kun Tsai, et al.
Published: (2007-05-01)

Dynamic Monitoring of Intracellular Tacrolimus and Mycophenolic Acid Therapy in Renal Transplant Recipients Using Magnetic Bead Extraction Combined with LC-MS/MS
by: Huan Xu, et al.
Published: (2023-09-01)

Population Pharmacokinetics of Mycophenolic Acid in Renal Transplant Patients: A Comparison of the Early and Stable Posttransplant Stages
by: Peile Wang, et al.
Published: (2022-05-01)

Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
by: Hyeyoung Kim, et al.
Published: (2014-09-01)

Effect of cytochrome P450 3A5 polymorphism on the pharmacokinetics of tacrolimus in renal transplant recipients
by: Yi Yi Htun, et al.
Published: (2020-03-01)

A Physiologically Based Pharmacokinetic Approach to Recommend an Individual Dose of Tacrolimus in Adult Heart Transplant Recipients
by: Ling Pei, et al.
Published: (2023-11-01)

A Volumetric Absorptive Microsampling UPLC-MS/MS Method for Simultaneous Quantification of Tacrolimus, Mycophenolic Acid and Creatinine in Whole Blood of Renal Transplant Recipients
by: Xueqiao Wang, et al.
Published: (2022-11-01)

Pharmacokinetic study of mycophenolic acid in Iranian kidney transplant patients.
by: Kheirollah Gholami, et al.
Published: (2015-10-01)

Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients
by: P Dalal, et al.
Published: (2010-08-01)

Safety of Tacrolimus Monotherapy within 12 Months after Liver Transplantation in the Era of Reduced Tacrolimus and Mycophenolate Mofetil: National Registry Study
by: Deok Gie Kim, et al.
Published: (2022-05-01)

Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients – a pilot study
by: Stenstrøm Jean, et al.
Published: (2009-07-01)

Number of Regularly Prescribed Drugs and Intrapatient Tacrolimus Trough Levels Variability in Stable Kidney Transplant Recipients
by: Piotr Giza, et al.
Published: (2020-06-01)

Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients
by: Hyunmin Ko, et al.
Published: (2021-03-01)

Celiac-like Enteropathy Associated With Mycophenolate Sodium in Renal Transplant Recipients
by: Vassilis Filiopoulos, MD, et al.
Published: (2018-08-01)

Tacrolimus monitoring in hair samples of kidney transplant recipients
by: Alexander Born, et al.
Published: (2023-12-01)

Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation
by: O Manuel, et al.
Published: (2007-12-01)

Nonlinear relationship between enteric-coated mycophenolate sodium dose and mycophenolic acid exposure in Han kidney transplantation recipients
by: Jun Zhang, et al.
Published: (2017-05-01)

Usefulness of limited sampling strategy for mycophenolic acid area under the curve considering postoperative days in living-donor renal transplant recipients with concomitant prolonged-release tacrolimus
by: Tomoyuki Enokiya, et al.
Published: (2017-06-01)

Effect of Protein Binding on Exposure of Unbound and Total Mycophenolic Acid: A Population Pharmacokinetic Analysis in Chinese Adult Kidney Transplant Recipients
by: Changcheng Sheng, et al.
Published: (2020-03-01)

Wuzhi Capsule Dosage Affects Tacrolimus Elimination in Adult Kidney Transplant Recipients, as Determined by a Population Pharmacokinetics Analysis
by: Chen L, et al.
Published: (2021-09-01)

Prospective population pharmacokinetic study of tacrolimus in adult recipients early after liver transplantation: A comparison of Michaelis-Menten and theory-based pharmacokinetic models
by: Xiao-Jun Cai, et al.
Published: (2022-11-01)

Estimation of Tacrolimus Clearance in Saudi Adult Kidney Transplant Recipients
by: Saeed Alqahtani, et al.
Published: (2021-01-01)

Sex-Specific Responses to Tacrolimus and Mycophenolate Mofetil in Spontaneously Hypertensive Rats
by: Rodrigo Oscar Marañón, et al.
Published: (2023-11-01)

Analysis of the Clinical Effects of the Combination of Mycophenolate Mofetil with Either Tacrolimus or Cyclophosphamide
by: Xuebing Zhang, et al.
Published: (2020-11-01)

The Effect of Tacrolimus and Mycophenolic Acid on CD14+ Monocyte Activation and Function.
by: Nynke M Kannegieter, et al.
Published: (2017-01-01)

Population pharmacokinetics of mycophenolate mofetil in pediatric patients early after liver transplantation
by: Yinyi Wei, et al.
Published: (2022-10-01)